The Role of Artificial Intelligence in Clinical Trials for Autism and Neurobehavioral Disorders
Artificial intelligence, including generative AI, is being explored to support clinical trials for autism and neurobehavioral disorders, offering data integration benefits but requiring careful ethical oversight.
Brief Observation of Social Communication Change (BOSCC) Shows Promise in Tracking Social Communication Improvements in Autism
A rapid review of 19 studies suggests the Brief Observation of Social Communication Change (BOSCC) effectively detects subtle improvements in social communication among autistic children, outperforming traditional diagnostic tools in some areas.
Key Insights from Autism Drug Development Inform Future Research Strategies
Experts highlight lessons from autism drug trials, emphasizing patient-focused outcomes, targeted populations, and improved trial designs to enhance future therapeutic development.
New Study Defines Meaningful Change Thresholds on Social Responsiveness Scale for Autistic Children
A new study establishes minimal clinically important difference values for the Social Responsiveness Scale in autistic children aged 4 to 10, aiding interpretation of treatment effects.